|
|
|
Volumn 8, Issue 6, 2005, Pages 483-486
|
|
Challenges in advancing the field of gene therapy - American society of gene therapy stakeholders' meeting. A critical review of the science, medicine and regulation. 7-8 April 2005, Arlington, VA, USA
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOVIRUS VECTOR;
ALPHA 1 ANTITRYPSIN;
AMINOGLYCOSIDE;
BLOOD CLOTTING FACTOR 9;
CANCER VACCINE;
LENTIVIRUS VECTOR;
NERVE GROWTH FACTOR;
NEUROTROPHIN 3;
PARVOVIRUS VECTOR;
PROTEINASE INHIBITOR;
RETROVIRUS VECTOR;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
BIOTECHNOLOGY;
CANCER;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIABETIC NEUROPATHY;
FANCONI ANEMIA;
FOLLOW UP;
GENE EXPRESSION;
GENE FUNCTION;
GENE TRANSFER;
GENE VECTOR;
HEMATOPOIESIS;
HEMATOPOIETIC STEM CELL;
HEMOPHILIA B;
HUMAN;
IMMUNOGENICITY;
IMMUNOLOGY;
MUSCULAR DYSTROPHY;
MUTAGENESIS;
NONHUMAN;
SIDE EFFECT;
VIRAL GENE THERAPY;
ALLERGY AND IMMUNOLOGY;
ANIMALS;
CANCER VACCINES;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
GENETICS, MEDICAL;
HUMANS;
INVESTMENTS;
|
|
EID: 20344388270
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
